There are new developments in the reform of state-owned hospitals! Recently, according to the industry media "visibility EKnower" reported that the State Grid will let the country in the health of 50% of the shares, by the same SASAC subordinate vice-ministerial central enterprises China General Technology (Group) Holdings Limited company to take over the management of the right to belong to the China General Technology Group, the State Grid is no longer involved in the operation and management.
9 hospitals under the flag, the group was established only two years
It is understood that the State China Healthcare Group Limited was established on June 6, 2018, is a wholly-owned subsidiary of the State Grid Corporation Limited.
The group has a registered capital of 3 billion yuan, and owns 9 medical institutions, including 2 level 3 general hospitals, 1 level 3 specialized hospital, 5 level 2A hospitals and 1 occupational disease prevention and treatment hospital managed with reference to level 2A hospitals.
At the time of its formation, China HealthCare positioned itself to focus on the health and pension industry, with health as the main line, medical care as the foundation, and pension as the core, and to create a new intelligent health and pension platform through the construction of the whole industry chain of health care, health management, medical care, health tourism, and "Internet +".
At the inauguration ceremony, Mr. Zhang Gang, Chairman of Guozhong Kangjian, said that Guozhong Kangjian would make use of social resources to carry out professional management and operation, and strive to develop into a professional health care industry group with 10,000 beds within 10 years.
At that time, the relevant person in charge of the country in the health to let 25% of the shares, the State Grid's future shareholding will be reduced to 25%, the actual controller will be changed to the State-owned Assets Supervision and Administration Commission. The other 50% of the shares have been two intended partners in the talks.
Now, 50% of the shares of the state in the health has been determined to spend on China General Technology Group, if the future proportion of the State Grid's shareholding to reduce to 25%, the follow-up or will continue to let the shares.
The receiver operates more than 20,000 beds
It is understood that China General Technology Group is approved by the State Council's State-owned Assets Supervision and Administration Commission to pharmaceuticals as one of the main industry of the three central enterprises, but also approved to participate in the state-owned enterprises to run the health care institutions of the resources of the central enterprises of the one of the six, the business field covers the pharmaceutical industry The company's business covers the pharmaceutical industry and other fields, forming a relatively complete industrial chain.
Pharmaceuticals, healthcare and wellness is one of the three core businesses of China General Technology Group. in 2017, the pharmaceutical industry ranked 51st in the country, and pharmaceutical business ranked 7th in the country.
According to the introduction, the group*** has 4 listed companies, including 2 in the pharmaceutical and healthcare sector, namely China Pharmaceutical (600056.SH) and Global Healthcare (02666.HK).
The official website of the Group shows that its medical service business actively undertakes medical institutions divested by state-owned enterprises and central enterprises, and has undertaken the integration of 87 medical institutions with 21,300 operating beds; the Group is also able to provide comprehensive medical services integrating financing, equipment, technology, and training for its hospital clients, with more than 1,000 hospital clients and over 60 international top-level With more than 1,000 hospital clients and more than 60 top international medical institution partners, the Group has become a leading large-scale integrated medical service provider in China.
In taking over the management of Guozhong Kangjian, Xu Xianping, Chairman of China General Technology Group, said that Guozhong Kangjian has a good medical foundation and a large customer base, and that by adhering to the principle of marketization and participating in the diversification of Guozhong Kangjian's shareholding in accordance with the market-based mechanism, the cooperation between the two sides will be promoted ****win***, and ****together we will build a first-class competitive health care and pension industry group.
In-depth Expansion of Hospital Group Business
According to another report from the medical management community, in 2019, Global Healthcare has signed project cooperation contracts with Anshan Iron & Steel Group, Pangang Group, China Electronics, China Railway State-owned Assets, and Yang Coal Group by means of joint venture and new establishment, and open-market offloading, and continues to participate actively in the It continues to actively participate in the integration and undertaking of hospitals run by state-owned enterprises, and comprehensively improves the technical level, management efficiency and service capacity of hospitals by focusing on multiple lines, such as discipline construction, operation and management, information technology upgrading, supply chain management, and hospital reconstruction and expansion.
2019 is a critical year for Global Healthcare to build a medical and healthcare industrial group and promote the implementation of strategic upgrading. The scale of the hospital group continued to expand, the healthcare finance business developed steadily, and the foundation of the group was initially formed.In 2019, the Company achieved a year-on-year growth of 58.6% in revenue to RMB6,815.6 million, a year-on-year growth of 21.0% in profit for the year to RMB1,634.4 million, and a year-on-year growth of 10.1% in profit attributable to ordinary equity holders for the year to RMB1,488.7 million.
As of December 31, 2019, the Company had contracted more than 40 medical institutions (including 5 tertiary hospitals and more than 20 secondary hospitals) with more than 15,000 open hospital beds. In the same year, the consolidation of 24 medical institutions (including 3 tertiary hospitals and 12 secondary hospitals) was realized, and the business operation performance of the hospital group made a breakthrough expansion, achieving a revenue of RMB2,046.9 million, representing an increase of RMB1,915.2 million as compared with the same period of the previous year. Profit for the year was RMB107.5 million, an increase of RMB115.3 million over the same period last year.
The Company has been actively extending its healthcare chain around the hospital group. In terms of medical technology, the Company introduces cutting-edge medical device products from around the world to effectively enhance the medical technology level of its hospital customers. In the medical information technology business, with member hospitals as the base, with Internet health services, intelligent hospital solutions, medical big data and artificial intelligence services as the core of the three main lines, constantly improve the Internet health platform, and strive to create "online + offline" service model. In the supply chain management business, focusing on the hospital business, the pharmaceutical supply chain system and medical supplies sunshine procurement management platform construction and deployment; sorting out the current situation of the use of drugs and medical supplies in hospitals, and constantly improve the business process, standardize the regionalization of the pharmaceutical supply chain procurement work.
State-owned hospital restructuring is still in progress
Data shows that there were more than 7,000 enterprise hospitals in our country, which accounted for nearly two-thirds of the public hospital system. In the 1980s, coal mines, iron and steel and other state-owned enterprises are generally better, enterprise hospital treatment and benefits are better than the government-sponsored public hospitals, is the first choice of many medical graduates. Now, this once tempting "meat and potatoes" is gradually withdrawing from the stage of history.
In March 2016, the State Council on the issuance of accelerated divestment of state-owned enterprises to run the social functions and solve the historical legacy of the notice of the work program" (Guo Fa [2016] No. 19) clearly defined the state-owned enterprises to run the deep reform of the medical institutions of the objectives and tasks, the requirements of the end of 2018 basically complete the deep reform of the state-owned enterprises to run the medical institutions.
In 2017, six state ministries and commissions issued the "Guiding Opinions on the Deepening Reform of State-owned Enterprises-run Educational and Medical Institutions", which required the basic completion of the restructuring and transfer of state-owned enterprises-run medical institutions and centralized management before the end of 2018, and made clear the four paths of the deepening of the reform of medical institutions: transfer to the local level, closure and revocation, resource integration, and reorganization and restructuring.
In July 2018, SASAC also designated six central enterprises, including China Resources Health, Sinopharm, China Chengtong, China General Motors, China Guotou, and China Guoxin, as hosting platforms, and assigned state-owned enterprise hospitals that had not completed their restructuring to hosting platforms.
However, the restructuring of enterprise hospitals, which was originally scheduled to be completed by the end of 2018, has been delayed at the national level from the original end of 2018 to 2021 due to the more difficult and slow progress of the divestment process and the difficulty of the reform.
According to Health News, at the end of 2019, the National Conference on Corporate Hospitals and the annual meeting of the Corporate Hospital Branch of the China Hospital Association, Jin Yongcheng, director of the Corporate Hospital Branch of the China Hospital Association, introduced the reform of the stripping of hospitals in state-owned enterprises to the present time, the stripping of corporate hospitals is mainly carried out according to a few ways:
First, the transfer of the local government and the university;
Second, the transfer of corporate hospitals through the Asset transfer, gratuitous transfer, trusteeship and other ways of resource integration;
Third, reorganization and restructuring.
Medical group industrialization, market-oriented advantage is that the enterprise hospital side business into the main business, capital investment and channels to be resolved, however, still facing survival and development challenges, such as compensation mechanism is not in place and other difficulties.
Jin Yongcheng said that by the end of 2018, 90% of corporate hospitals have completed the task of divestment. However, due to the large scale of investment in medical institutions, the long return cycle, and the difficulty of realizing, the enthusiasm of all capital investment has cooled significantly, and the reform and restructuring of corporate hospitals may have to continue for a long time.